Amyris Inc (NASDAQ:AMRS) posted record production of CBG (Cannabigerol) in Q1 2021 for skincare treatments. Amyris used the fermentation process to achieve record production of CBG...
Amyris Inc (NASDAQ:AMRS) posted record revenues of $80 million (up 71% QoQ) in Q4 2020. It is almost double to revenues in Q3 2020. Also, its...
Amyris Inc (NASDAQ:AMRS) has completed the first shipment of cannabinoids to its associate – LAVVAN. The company is also gearing to meet the second shipment of...